Cargando…

Incorporation of liver chemistry score in predicting survival of liver‐involved advanced gastric cancer patients who received palliative chemotherapy

BACKGROUND: Gastric cancer liver metastasis (GCLM) patients usually accompany by abnormal serum liver function tests (LFTs) more or less; however, the prognostic value of LFTs is not fully understood. This study aimed to develop a liver chemistry score (LCS) based on LFTs and incorporate it into pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Ying, Zhang, Cheng, Wu, Zhijun, Xu, Hui, Zhang, Xiaopeng, Feng, Chong, Shao, Jingyi, Xie, Minmin, Yang, Yahui, Zhang, Yi, Ma, Tai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939141/
https://www.ncbi.nlm.nih.gov/pubmed/36057969
http://dx.doi.org/10.1002/cam4.5179
_version_ 1784890781079699456
author Feng, Ying
Zhang, Cheng
Wu, Zhijun
Xu, Hui
Zhang, Xiaopeng
Feng, Chong
Shao, Jingyi
Xie, Minmin
Yang, Yahui
Zhang, Yi
Ma, Tai
author_facet Feng, Ying
Zhang, Cheng
Wu, Zhijun
Xu, Hui
Zhang, Xiaopeng
Feng, Chong
Shao, Jingyi
Xie, Minmin
Yang, Yahui
Zhang, Yi
Ma, Tai
author_sort Feng, Ying
collection PubMed
description BACKGROUND: Gastric cancer liver metastasis (GCLM) patients usually accompany by abnormal serum liver function tests (LFTs) more or less; however, the prognostic value of LFTs is not fully understood. This study aimed to develop a liver chemistry score (LCS) based on LFTs and incorporate it into prognosis determination for GCLM patients who received palliative chemotherapy. METHODS: Data were derived from hospitalized GCLM patients in two general hospitals in China. LCS was generated based on the results of LFTs by LASSO regression. Cutoff value of the score was determined by restricted cubic spline. The score was then incorporated into Cox regression analysis to construct a predictive nomogram; the model was then evaluated internally and externally by AUC of time‐dependent receiver operating characteristic curves (ROC) and calibration curves. RESULTS: Three hundred and thirty‐six and 72 patients were included in development and validation cohort, respectively. LASSO regression analysis in development cohort finally reached a two‐parametric LCS calculated on AST and ALP levels as 0.03343515 × ln (AST, U/L) + 0.02687997 × ln (ALP, U/L), and 0.232 was set as optimal cutoff value. Patients in low (LCS < 0.232) or high (LCS ≥ 0.232) score group experienced different survival times; median OS was 13.54 (95% CI: 11.1–15.6) months in the low LCS group and 7.3 (6.6–9.3) months in the high LCS group (p < 0.001). A nomogram including LCS and other clinical parameters was constructed and showed superior performance than model not including LCS. AUC of 6‐month ROC improved from 0.647 (95% CI: 0.584–0.711) to 0.699 (0.638–0.759) in internal validation, and 0.837 (0.734–0.940) to 0.875 (0.784–0.966) in external validation. CONCLUSIONS: Liver chemistry score is useful in determining the prognosis of gastric cancer patients with liver metastasis and may be helpful to clinicians in decision‐making.
format Online
Article
Text
id pubmed-9939141
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-99391412023-02-20 Incorporation of liver chemistry score in predicting survival of liver‐involved advanced gastric cancer patients who received palliative chemotherapy Feng, Ying Zhang, Cheng Wu, Zhijun Xu, Hui Zhang, Xiaopeng Feng, Chong Shao, Jingyi Xie, Minmin Yang, Yahui Zhang, Yi Ma, Tai Cancer Med RESEARCH ARTICLES BACKGROUND: Gastric cancer liver metastasis (GCLM) patients usually accompany by abnormal serum liver function tests (LFTs) more or less; however, the prognostic value of LFTs is not fully understood. This study aimed to develop a liver chemistry score (LCS) based on LFTs and incorporate it into prognosis determination for GCLM patients who received palliative chemotherapy. METHODS: Data were derived from hospitalized GCLM patients in two general hospitals in China. LCS was generated based on the results of LFTs by LASSO regression. Cutoff value of the score was determined by restricted cubic spline. The score was then incorporated into Cox regression analysis to construct a predictive nomogram; the model was then evaluated internally and externally by AUC of time‐dependent receiver operating characteristic curves (ROC) and calibration curves. RESULTS: Three hundred and thirty‐six and 72 patients were included in development and validation cohort, respectively. LASSO regression analysis in development cohort finally reached a two‐parametric LCS calculated on AST and ALP levels as 0.03343515 × ln (AST, U/L) + 0.02687997 × ln (ALP, U/L), and 0.232 was set as optimal cutoff value. Patients in low (LCS < 0.232) or high (LCS ≥ 0.232) score group experienced different survival times; median OS was 13.54 (95% CI: 11.1–15.6) months in the low LCS group and 7.3 (6.6–9.3) months in the high LCS group (p < 0.001). A nomogram including LCS and other clinical parameters was constructed and showed superior performance than model not including LCS. AUC of 6‐month ROC improved from 0.647 (95% CI: 0.584–0.711) to 0.699 (0.638–0.759) in internal validation, and 0.837 (0.734–0.940) to 0.875 (0.784–0.966) in external validation. CONCLUSIONS: Liver chemistry score is useful in determining the prognosis of gastric cancer patients with liver metastasis and may be helpful to clinicians in decision‐making. John Wiley and Sons Inc. 2022-09-04 /pmc/articles/PMC9939141/ /pubmed/36057969 http://dx.doi.org/10.1002/cam4.5179 Text en © 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle RESEARCH ARTICLES
Feng, Ying
Zhang, Cheng
Wu, Zhijun
Xu, Hui
Zhang, Xiaopeng
Feng, Chong
Shao, Jingyi
Xie, Minmin
Yang, Yahui
Zhang, Yi
Ma, Tai
Incorporation of liver chemistry score in predicting survival of liver‐involved advanced gastric cancer patients who received palliative chemotherapy
title Incorporation of liver chemistry score in predicting survival of liver‐involved advanced gastric cancer patients who received palliative chemotherapy
title_full Incorporation of liver chemistry score in predicting survival of liver‐involved advanced gastric cancer patients who received palliative chemotherapy
title_fullStr Incorporation of liver chemistry score in predicting survival of liver‐involved advanced gastric cancer patients who received palliative chemotherapy
title_full_unstemmed Incorporation of liver chemistry score in predicting survival of liver‐involved advanced gastric cancer patients who received palliative chemotherapy
title_short Incorporation of liver chemistry score in predicting survival of liver‐involved advanced gastric cancer patients who received palliative chemotherapy
title_sort incorporation of liver chemistry score in predicting survival of liver‐involved advanced gastric cancer patients who received palliative chemotherapy
topic RESEARCH ARTICLES
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939141/
https://www.ncbi.nlm.nih.gov/pubmed/36057969
http://dx.doi.org/10.1002/cam4.5179
work_keys_str_mv AT fengying incorporationofliverchemistryscoreinpredictingsurvivalofliverinvolvedadvancedgastriccancerpatientswhoreceivedpalliativechemotherapy
AT zhangcheng incorporationofliverchemistryscoreinpredictingsurvivalofliverinvolvedadvancedgastriccancerpatientswhoreceivedpalliativechemotherapy
AT wuzhijun incorporationofliverchemistryscoreinpredictingsurvivalofliverinvolvedadvancedgastriccancerpatientswhoreceivedpalliativechemotherapy
AT xuhui incorporationofliverchemistryscoreinpredictingsurvivalofliverinvolvedadvancedgastriccancerpatientswhoreceivedpalliativechemotherapy
AT zhangxiaopeng incorporationofliverchemistryscoreinpredictingsurvivalofliverinvolvedadvancedgastriccancerpatientswhoreceivedpalliativechemotherapy
AT fengchong incorporationofliverchemistryscoreinpredictingsurvivalofliverinvolvedadvancedgastriccancerpatientswhoreceivedpalliativechemotherapy
AT shaojingyi incorporationofliverchemistryscoreinpredictingsurvivalofliverinvolvedadvancedgastriccancerpatientswhoreceivedpalliativechemotherapy
AT xieminmin incorporationofliverchemistryscoreinpredictingsurvivalofliverinvolvedadvancedgastriccancerpatientswhoreceivedpalliativechemotherapy
AT yangyahui incorporationofliverchemistryscoreinpredictingsurvivalofliverinvolvedadvancedgastriccancerpatientswhoreceivedpalliativechemotherapy
AT zhangyi incorporationofliverchemistryscoreinpredictingsurvivalofliverinvolvedadvancedgastriccancerpatientswhoreceivedpalliativechemotherapy
AT matai incorporationofliverchemistryscoreinpredictingsurvivalofliverinvolvedadvancedgastriccancerpatientswhoreceivedpalliativechemotherapy